Prevalence of Hepatitis D in the United States
The Journal of Applied Laboratory Medicine · 03.09.2025 · 10 (5) · 1133-1139
DOI: 10.1093/jalm/jfaf092 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 08.07.2025. Verfasst von Derek L Stark und 3 weiteren Autor:innen. Beteiligte Einrichtung: ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States. Hauptthemen laut MEDLINE: Hepatitis D, Hepatitis Delta Virus, Hepatitis B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Hepatitis D virus (HDV) causes the most severe form of viral hepatitis and exclusively infects people who are also infected with hepatitis B virus (HBV). The global incidence of HDV is estimated to be 5.9%–14.6% of HBV infected individuals, however, the prevalence in the United States is unknown.
Methods
In this study, the prevalence of HDV in HBV infected individuals was determined by testing 1104 samples from a national laboratory that were positive for hepatitis B surface antigen with the anti-HDV total antibody ELISA from International Immuno Diagnostics.
Results
The prevalence of HDV using the described approach was 1.2% of HBV positive samples. HDV positivity did not correlate with HBV viral load, although the sample size may be insufficient to detect such an effect. HDV RNA, which is present during active infection, was detected in 33% of anti-HDV positive samples.
Conclusions
This provides a more reliable estimate for HDV prevalence in the United States that is lower than estimates from previous smaller studies and meta-analyses. A reliable estimate of HDV prevalence is increasingly important due to the advent of several new HDV therapies and the growing consensus among clinicians and professional societies that all HBV infected individuals should also be screened for HDV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
- Rocky Mountain Laboratories, Draper, UT, United States.
- ARUP Laboratories, Salt Lake City, UT, United States.
- Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
ORCID-Profile: Derek L Stark
Zitieren
APA
Stark, D. L., Falekun, S., Jorgensen, S., & Slev, P. (2025). Prevalence of Hepatitis D in the United States. The Journal of Applied Laboratory Medicine, 10(5), 1133-1139. https://doi.org/10.1093/jalm/jfaf092
Vancouver
Stark DL, Falekun S, Jorgensen S, Slev P. Prevalence of Hepatitis D in the United States. The Journal of Applied Laboratory Medicine. 2025;10(5):1133-1139. doi:10.1093/jalm/jfaf092
BibTeX
@article{Stark2025,
author = {Stark, Derek L and Falekun, Seyi and Jorgensen, Shane and Slev, Patricia},
title = {Prevalence of Hepatitis D in the United States},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
volume = {10},
number = {5},
pages = {1133--1139},
doi = {10.1093/jalm/jfaf092}
}
EUVIMED